Unlearn AI

Unlearn.AI specializes in using AI to generate synthetic data for clinical trials in the pharmaceutical and healthcare industries.

Unlearn.AI develops artificial intelligence (AI) technology to create digital twins of clinical trial participants. These digital twins are virtual models that predict patient health outcomes over time. The company uses this technology to streamline and accelerate clinical trials, reducing the number of participants needed in control groups and potentially speeding up the drug development process.

Deep 6 AI

Deep 6 AI finds patients for clinical trials in minutes rather than months, bringing life-saving cures to people faster.

Deep 6 AI is a technology company that specializes in accelerating clinical trials through artificial intelligence. They have developed software that uses natural language processing and concept mapping to analyze both structured and unstructured patient data, including physician notes, pathology reports, and lab results.